Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro

Brain Research

Volumn 997, Issue 1, 2004, Pages 1-14

  Lees, George ^a   Dougalis, Antonios ^a  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

Anandamide transport inhibitor; Cannabinoid; cis 9,10 Octadecenoamide (oleamide); Fatty acid amide hydrolase; High frequency stimulation; Synaptic plasticity; Burst

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1,1,1 TRIFLUORONONADECEN 2 ONE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; FATTY ACID; FLUORINE DERIVATIVE; HYDROLASE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; OLEAMIDE; PICROTOXIN; RIMONABANT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DRUG DEGRADATION; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; DRUG UPTAKE; ENZYME INHIBITION; GABAERGIC TRANSMISSION; HIPPOCAMPUS; IN VITRO STUDY; LONG TERM POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SLEEP INDUCTION; STEREOCHEMISTRY; SYNAPSE;

EID: 0346094445     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.10.019     Document Type: Article

References (86)

1. Adams J.P., Sweatt J.D. Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu. Rev. Pharmacol Toxicol. 42:2002;135-163.
2. Ahluwalia J., Urban L., Capogna M., Bevan S., Nagy I. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience. 100:2000;685-688.
3. Al Hayani A., Davies S.N. Effect of cannabinoids on synaptic transmission in the rat hippocampal slice is temperature-dependent. Eur. J. Pharmacol. 442:2000;47-54.
4. Al Hayani A., Wease K.N., Ross R.A., Pertwee R.G., Davies S.N. The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology. 41:2001;1000-1005.
5. Ameri A., Wilhelm A., Simmet T. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br. J. Pharmacol. 126:1999;1831-1839.
6. Anderson W.W., Collingridge G.L. The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J. Neurosci. Methods. 108:2001;71-83.
7. Basile A.S., Hanus L., Mendelson W.B. Characterization of the hypnotic properties of oleamide. Neuroreport. 10:1999;947-951.
8. 35S]GTPγS binding in the rat brain. Br. J. Pharmacol. 128:1999;92.
9. Beltramo M., Stella N., Calignano A., Lin S.Y., Makriyannis A., Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science. 277:1997;1094-1097.
10. Beltramo M., de Fonseca F.R., Navarro M., Calignano A., Gorriti M.A., Grammatikopoulos G., Sadile A.G., Giuffrida A., Piomelli D. Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. J. Neurosci. 20:2000;3401-3407.
11. Berdyshev E.V., Schmid P.C., Krebsbach R.J., Hillard C.J., Huang C., Chen N., Dong Z., Schmid H.H. Cannabinoid-receptor-independent cell signalling by N-acylethanolamines. Biochem. J. 360:2001;67-75.
12. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
13. Boger D.L., Henriksen S.J., Cravatt B.F. Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules. Curr. Pharm. Des. 4:1998;303-314.
14. Boger D.L., Patterson J.E., Jin Q. Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide. Proc. Natl. Acad. Sci. U. S. A. 95:1998;4102-4107.
15. Boger D.L., Fecik R.A., Patterson J.E., Miyauchi H., Patricelli M.P., Cravatt B.F. Fatty acid amide hydrolase substrate specificity. Bioorg. Med. Chem. Lett. 10:2000;2613-2616.
16. Boger D.L., Sato H., Lerner A.E., Hedrick M.P., Fecik R.A., Miyauchi H., Wilkie G.D., Austin B.J., Patricelli M.P., Cravatt B.F. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc. Natl. Acad. Sci. U. S. A. 97:2000;5044-5049.
17. Boring D.L., Berglund B.A., Howlett A.C. Cerebrodiene, arachidonyl-ethanolamide and hybrid structures: potential for interaction with brain cannabinoid receptors. Prostaglandins Leukot. Essent. Fat. Acids. 55:1996;207-210.
18. Bortolotto Z.A., Bashir Z.I., Davies C.H., Taira T., Kaila K., Collingridge G.L. Studies on the role of metabotropic glutamate receptors in long-term potentiation: some methodological considerations. J. Neurosci. Methods. 59:1995;19-24.
19. Cheer J.F., Cadogan A.K., Marsden C.A., Fone K.C., Kendall D.A. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology. 38:1999;533-541.
20. Collingridge G. Synaptic plasticity. The role of NMDA receptors in learning and memory. Nature. 330:1987;604-605.
21. Collins D.R., Pertwee R.G., Davies S.N. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Br. J. Pharmacol. 115:1995;869-870.
22. Compton D.R., Martin B.R. The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. J. Pharmacol. Exp. Ther. 283:1997;1138-1143.
23. Corradetti R., Ballerini L., Pugliese A.M., Pepeu G. Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience. 46:1992;511-518.
24. Coyne L., Lees G., Nicholson R.A., Zheng J., Neufield K.D. The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro. Br. J. Pharmacol. 135:2002;1977-1987.
25. Cravatt B.F., Prospero-Garcia O., Siuzdak G., Gilula N.B., Henriksen S.J., Boger D.L., Lerner R.A. Chemical characterization of a family of brain lipids that induce sleep. Science. 268:1995;1506-1509.
26. Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A., Gilula N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 384:1996;83-87.
27. B autoreceptors in rat hippocampus. J. Physiol. 472:1993;245-265.
28. B autoreceptors in rat hippocampus. J. Physiol. 496(Pt 2):1996;451-470.
29. Davies C.H., Starkey S.J., Pozza M.F., Collingridge G.L. GABA autoreceptors regulate the induction of LTP. Nature. 349:1991;609-611.
30. Davies S.N., Pertwee R.G., Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology. 42:2002;993-1007.
31. De Petrocellis L., Bisogno T., Davis J.B., Pertwee R.G., Di Marzo V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett. 483:2000;52-56.
32. Di Marzo V. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim. Biophys. Acta. 1392:1998;153-175.
33. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686-691.
34. Di Marzo V., Bisogno T., Melck D., Ross R., Brockie H., Stevenson L., Pertwee R., De Petrocellis L. Interactions between synthetic vanilloids and the endogenous cannabinoid system. FEBS Lett. 436:1998;449-454.
35. Dougalis A., Lees G., Ganellin C.R. The sleep inducing brain lipid cis-oleamide (cOA) does not modulate serotonergic transmission in the CA1 pyramidal neurons of the hippocampus in vitro. Neuropharmacology. 46:2003;63-73.
36. Egertova M., Giang D.K., Cravatt B.F., Elphick M.R. A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc. R. Soc. Lond., B Biol. Sci. 265:1998;2081-2085.
37. A receptors. Neuropharmacology. 35:1996;347-357.
38. Fedorova I., Hashimoto A., Fecik R.A., Hedrick M.P., Hanus L.O., Boger D.L., Rice K.C., Basile A.S. Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J. Pharmacol. Exp. Ther. 299:2001;332-342.
39. Giuffrida A., Rodriguez D.F., Nava F., Loubet-Lescoulie P., Piomelli D. Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. Eur. J. Pharmacol. 408:2000;161-168.
40. Gobbi M., Mennini T., Valle F.D., Cervo L., Salmona M., Diomede L. Oleamide-mediated sleep induction does not depend on perturbation of membrane homeoviscosity. FEBS Lett. 463:1999;281-284.
41. Guan X., Cravatt B.F., Ehring G.R., Hall J.E., Boger D.L., Lerner R.A., Gilula N.B. The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells. J. Cell Biol. 139:1997;1785-1792.
42. Hajos N., Freund T.F. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology. 43:2002;503-510.
43. Hajos N., Katona I., Naiem S.S., MacKie K., Ledent C., Mody I., Freund T.F. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci. 12:2000;3239-3249.
44. Hillard C.J., Edgemond W.S., Jarrahian A., Campbell W.B. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem. 69:1997;631-638.
45. Hoffman A.F., Lupica C.R. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J. Neurosci. 20:2000;2470-2479.
46. Howlett A.C., Mukhopadhyay S. Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem. Phys. Lipids. 108:2000;53-70.
47. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., MacKie K., Martin B.R., Mechoulam R., Pertwee R.G. International Union of Pharmacology: XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54:2002;161-202.
48. Huidobro-Toro J.P., Harris R.A. Brain lipids that induce sleep are novel modulators of 5-hydroxytryptamine receptors. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8078-8082.
49. Kagaya M., Lamb J., Robbins J., Page C.P., Spina D. Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. Br. J. Pharmacol. 137:2002;39-48.
50. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., MacKie K., Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19:1999;4544-4558.
51. Kirby M.T., Hampson R.E., Deadwyler S.A. Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus. Brain Res. 863:2000;120-131.
52. Laposky A.D., Homanics G.E., Basile A., Mendelson W.B. Deletion of the GABA(A) receptor beta 3 subunit eliminates the hypnotic actions of oleamide in mice. NeuroReport. 12:2001;4143-4147.
53. Larson J., Lynch G. Role of N-methyl-D-aspartate receptors in the induction of synaptic potentiation by burst stimulation patterned after the hippocampal theta-rhythm. Brain Res. 441:1988;111-118.
54. Lees G., Edwards M.D., Hassoni A.A., Ganellin C.R., Galanakis D. Modulation of GABA(A) receptors and inhibitory synaptic currents by the endogenous CNS sleep regulator cis-9,10-octadecenoamide (cOA). Br. J. Pharmacol. 124:1998;873-882.
55. 35S GTPγS binding in rat brain preparations via a cannabinoid receptor. Brit. J. Pharmacol. 137:2002;114.
56. Lichtman A.H., Hawkins E.G., Griffin G., Cravatt B.F. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J. Pharmacol. Exp. Ther. 302:2002;73-79.
57. Mechoulam R., Fride E., Hanus L., Sheskin T., Bisogno T., Di Marzo V., Bayewitch M., Vogel Z. Anandamide may mediate sleep induction. Nature. 389:1997;25-26.
58. Mendelson W.B., Basile A.S. The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist. NeuroReport. 10:1999;3237-3239.
59. Millns P.J., Chapman V., Kendall D.A. Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones. Br. J. Pharmacol. 132:2001;969-971.
60. Misner D.L., Sullivan J.M. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J. Neurosci. 19:1999;6795-6805.
61. Moore R.Y., Halaris A.E. Hippocampal innervation by serotonin neurons of the midbrain raphe in the rat. J. Comp. Neurol. 164:1975;171-183.
62. Murillo-Rodriguez E., Sanchez-Alavez M., Navarro L., Martinez-Gonzalez D., Drucker-Colin R., Prospero-Garcia O. Anandamide modulates sleep and memory in rats. Brain Res. 812:1998;270-274.
63. Murillo-Rodriguez E., Giordano M., Cabeza R., Henriksen S.J., Mendez D.M., Navarro L., Prospero-Garcia O. Oleamide modulates memory in rats. Neurosci. Lett. 313:2001;61-64.
64. Murillo-Rodriguez E., Cabeza R., Mendez-Diaz M., Navarro L., Prospero-Garcia O. Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. NeuroReport. 12:2001;2131-2136.
65. Nguyen P.V., Kandel E.R. Brief theta-burst stimulation induces a transcription-dependent late phase of LTP requiring cAMP in area CA1 of the mouse hippocampus. Learn. Mem. 4:1997;230-243.
66. Nicholson R.A., Zheng J., Ganellin C.R., Verdon B., Lees G. Anesthetic-like interaction of the sleep-inducing lipid oleamide with voltage-gated sodium channels in mammalian brain. Anesthesiology. 94:2001;120-128.
67. Nowicky A.V., Teyler T.J., Vardaris R.M. The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro. Brain Res. Bull. 19:1987;663-672.
68. Paton G.S., Pertwee R.G., Davies S.N. Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal slice. Neuropharmacology. 37:1998;1123-1130.
69. Pertwee R.G., Fernando S.R., Griffin G., Abadji V., Makriyannis A. Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Eur. J. Pharmacol. 272:1995;73-78.
70. A receptor benzodiazepine site ligands. Neuropharmacology. 36:1997;823-830.
71. Shah Y., Roe C., Beckett S., Marsden C.A., Kendall D.A. Lack of effect of oleamide on extracellular dopamine and 5-HT in the striatum and accumbens of the rat. Br. J. Pharmacol. 128:2000;. (122 pp.).
72. Smart D., Gunthorpe M.J., Jerman J.C., Nasir S., Gray J., Muir A.I., Chambers J.K., Randall A.D., Davis J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 129:2000;227-230.
73. Staubli U., Otaky N. Serotonin controls the magnitude of LTP induced by theta bursts via an action on NMDA-receptor-mediated responses. Brain Res. 643:1994;10-16.
74. Staubli U., Xu F.B. Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory and LTP induction in the freely moving rat. J. Neurosci. 15:1995;2445-2452.
75. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 388:1997;773-778.
76. Szallasi A., Di Marzo V. New perspectives on enigmatic vanilloid receptors. Trends Neurosci. 23:2000;491-497.
77. Terranova J.P., Michaud J.C., Le Fur G., Soubrie P. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;576-579.
78. Thomas E.A., Carson M.J., Neal M.J., Sutcliffe J.G. Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide. Proc. Natl. Acad. Sci. U. S. A. 94:1997;14115-14119.
79. Thomas E.A., Carson M.J., Sutcliffe J.G. Oleamide-induced modulation of 5-hydroxytryptamine receptor-mediated signaling. Ann. N.Y. Acad. Sci. 861:1998;183-189.
80. Tognetto M., Amadesi S., Harrison S., Creminon C., Trevisani M., Carreras M., Matera M., Geppetti P., Bianchi A. Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J. Neurosci. 21:2001;1104-1109.
81. Tucker R.C., Kagaya M., Page C.P., Spina D. The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways. Br. J. Pharmacol. 132:2001;1127-1135.
82. Verdon B., Zheng J., Nicholson R.A., Ganelli C.R., Lees G. Stereoselective modulatory actions of oleamide on GABA(A) receptors and voltage-gated Na(+) channels in vitro: a putative endogenous ligand for depressant drug sites in CNS. Br. J. Pharmacol. 129:2000;283-290.
83. Winder D.G., Martin K.C., Muzzio I.A., Rohrer D., Chruscinski A., Kobilka B., Kandel E.R. ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by beta-adrenergic receptors. Neuron. 24:1999;715-726.
84. Yost C.S., Hampson A.J., Leonoudakis D., Koblin D.D., Bornheim L.M., Gray A.T. Oleamide potentiates benzodiazepine-sensitive gamma-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration. Anesth. Analg. 86:1998;1294-1300.
85. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., Julius D., Hogestatt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 400:1999;452-457.
86. Zygmunt P.M., Chuang H., Movahed P., Julius D., Hogestatt E.D. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur. J. Pharmacol. 396:2000;39-42.